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Purpose: We report a case of renal cell carcinoma adrenal metastasis after
nephrectomy and spontaneous regression of metastases after short-term
treatment with sunitinib.
Case report: A 55-year-old man presented with chronic testicular pain and
ultrasonography of the abdomen detected left renal tumor. Computerized
tomography (CT) showed a heterogeneous left upper pole renal tumor
(5.3 cm in diameter). Laparoscopic radical nephrectomy was carried out in
May 2008. Histology disclosed clear cell type renal cell carcinoma and the
surgical marginwas free (pathological stage T2N0M0). No tumor recurrence
(CT scan every 6 months) was found until 51 months later. Two nodules (1.8
and 0.9 cm) in the renal fossa were detected by CT scan. Retroperitoneal
exploration conﬁrmed recurrent clear cell carcinoma with microscopically
positive surgical margins. Four months after excision, abdominal CT showed
a nodule (1.6 cm) over right adrenal gland. A repeat CT evaluation 6 months
later conﬁrmed disease progression of adrenal metastasis (2.1cm). He was
treatedwith sunitinib (37.5mg/day) for 4weeks, but discontinuedas a result
of gastrointestinal upset and fatigue. Three months later, CT scan showed
adrenal metastasis progression (3.8cm). The patient refused the suggestion
of right adrenalectomy. Eleven months after sunitinib treatment, obvious
disease progression of adrenal metastasis (5.7 cm) was demonstrated on CT
scan. However, 16 months after sunitinib, delay regression of adrenal me-
tastases (3.4cm)wasdetected. Twenty-twomonths after sunitinib, gradually
diminishing of the adrenal metastasis (1.8 cm) was found by CT scan.
To our knowledge, this is the fourth case of spontaneous regression of
metastatic renal cell carcinoma after sunitinib withdrawal.
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Purpose: Horseshoe kidney is the most common renal fusion disease has
an incident rate from 1 in 1000 up to 1 in 400. Patients with this disease are
often asymptomatic until incidental image ﬁnding for other reason. Ｍ
Meanwhile, the incidence of renal cell carcinoma and the correlation to
horseshoe kidney disease remains unclear and there were only few case
reports to date. Partial nephrectomy has becoming gold standard treat-
ment for renal tumors and the most important issue during surgery is the
variable blood supplies of the horseshoe kidney. We reported a case that
was diagnosed with renal cell carcinoma conﬁned in the isthmus of a
horseshoe kidney and treated by laparoscopic partial nephrectomy.
Case Report: A 48-year-old woman presented epigastralgia and a solid
renal tumor with calciﬁcation conﬁned in the isthmus, close to the right
moiety, of a horseshoe kidney was incidentally detected by computed to-
mography. Followed angiography of kidney revealed there were one renal
artery and one lower polar artery at both sides and the tumor was supplied
bya branch fromright lower polar artery. Laparoscopic partial nephrectomy
was performed under left lateral decubitus surgical position. Right lower
polar artery was controlled by bulldog and feeding artery of the tumor was
ligated before tumor resection. The left border of the tumor was also
resected with isthmusectomy procedure without pedicle control. The
laparoscopic procedure time was 178 minutes with selective artery
clamping 32 minutes and the estimated blood loss was 100 ml. The ﬁnal
pathology revealed a pT1a multilocular cystic renal cell carcinoma, a rare
subtype. The patient was discharged on post-operative day without com-
plications and there was no evidence of recurrence at one-year follow-up.
NDP040:
ACCURACY OF MAGNETIC RESONANCE IMAGING FOR PROSTATE
CANCER: EXPERIENCE IN CHANGHUA CHRISTIAN HOSPITAL
You-Chiuan Chien, Bai-Fu Wang. Divisions of Urology, Department of
Surgery, Changhua Christian Hospital, Changhua, TaiwanPurpose: To evaluate the accuracy of MRI acquisition for staging of pros-
tate cancer (PCa) in robot-assisted laparoscopic radical prostatectomy
(RALAP).
Materials and Methods: 33 consecutive patients underwent a multi-
parametric MRI protocol prior to RALAP. Analyses were carried out to
predict side-speciﬁc extracapsular extension (ECE) using variables
determined preoperatively, including 3.0-Tesla magnetic resonance im-
aging ﬁndings (T2-weighted and diffusion-weighted imaging). A predic-
tion model was then constructed and applied to the validation study
sample.
Results: Of 33 eligible patients, histology showed ECE in 14 (42%) cases.
MRI sensitivity and speciﬁcity to detect ECE were 40 and 86%.
Conclusion: MRI provides a high speciﬁcity and relatively low sensitivity
for local staging of prostate cancer.
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FEMALE URETHRAL INTESTINAL TYPE ADENOCARCINOMA: CASE
REPORT AND REVIEW OF LITERATURE
Chu-Hsuan Hung, Kuo-Chiang Chen. Divisions of Urology, Department of
Surgery, Cathay General Hospital, Taipei, Taiwan
Primary urethral cancer is a rare malignancy in women, and adenocarci-
noma accounts a less proportion. Nevertheless, most of adenocarcinoma
was clear cell type, intestinal type was more uncommon. The published
data on this topic are limited.
We report a case of a 64 year-old woman presenting with gross hematuria.
Physical examination revealed a cauliﬂower reddish mass, 1.4cm in size, at
external urethral meatus. Cystoscopy revealed no abnormal condition.
Urethral caruncle was suspected initially. Hematuria was improved after
treatment at outpatient department. However, hematuria exacerbated one
year later. After discussion with patient, urethral mass excision was per-
formed successfully with transurethral resection. Pathology reported in-
testinal type adenocarcinoma. The tumor stalk margin is free. In
immunochemical stains, the neoplastic cells are CDX2(+)/ GATA3(-)/
PAX8(-)/ b-catenin (-). The morphology and immunoproﬁles could be an
adenocarcinoma of urethra origin. However, the possibility of a metastatic
adenocarcinoma of colon origin could not be completely excluded. Further
colonoscopy revealed no organic lesion in whole colon. No further adju-
vant therapywas performed. No local recurrence or no systemicmetastasis
was detected during the 12-months follow-up period and two times cys-
toscopy.
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Purpose: Retroperitoneal leiomyosarcoma is a rare tumor of all soft tissue
sarcomas. We report on a 49-year-old female patient with history of
retroperitoneal leiomyosarcoma with bilateral renal metastases for nine-
year survival.
Case: This 49 year-old female was found to have retroperitoneal leio-
myosarcoma and underwent tumor resection in 2007. In 9-year of follow
up, she developed metastases to the paraspinal muscle, right upper lung
and left arm, for which she underwent multiple times of surgery and local
radiotherapy. Recurrent metastatic high-grade leiomyosarcoma involving
bilateral kidneys, sacrum, paraspinal muscle and pancreatic head devel-
oped during follow up. Bilateral partial nephrectomies were performed
and no recurrence of follow up in bilateral kidney and her renal function
was well preserved. The patient eventually died due of pancreatic head
metastasis.
Due to long survival time of leimyosarcoma, we suggest aggressively do
surgical intervention for renal metastatic tumor to keep life quality of
patient, especially for young patient. We discuss the treatment modalities
and the issues related to quality of life and psychological status in patients
with this deliberating disease.
